|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1996-11-22
|
|
pubmed:abstractText |
The immunosuppressant cyclosporine-A (CsA) is the primary drug for neural transplantation in Parkinson's disease. However, little is known of its direct effects on movement disorders. Our previous observation of increased locomotor activity in normal rats injected with CsA prompted us to investigate further the effects of CsA on hemiparkinsonian rats.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0090-3019
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
384-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8876721-Animals,
pubmed-meshheading:8876721-Brain,
pubmed-meshheading:8876721-Cyclosporine,
pubmed-meshheading:8876721-Dextroamphetamine,
pubmed-meshheading:8876721-Dopamine Agonists,
pubmed-meshheading:8876721-Immunosuppressive Agents,
pubmed-meshheading:8876721-Locomotion,
pubmed-meshheading:8876721-Male,
pubmed-meshheading:8876721-Oxidopamine,
pubmed-meshheading:8876721-Parkinson Disease,
pubmed-meshheading:8876721-Rats,
pubmed-meshheading:8876721-Rats, Sprague-Dawley,
pubmed-meshheading:8876721-Tissue Transplantation
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism: relevance to neural transplantation.
|
|
pubmed:affiliation |
Departments of Surgery, University of South Florida, College of Medicine, Tampa, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
